High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

Authors

  • In Keun Choi Division of Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
  • Yeul Hong Kim Division of Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
  • Jun Suk Kim Division of Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
  • Jae Hong Seo Division of Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea

DOI:

https://doi.org/10.3109/02841861003631503

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2010-08-01

How to Cite

Keun Choi, I., Hong Kim, Y., Suk Kim, J., & Hong Seo, J. (2010). High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer. Acta Oncologica, 49(6), 861–864. https://doi.org/10.3109/02841861003631503

Issue

Vol. 49 No. 6 (2010): Acta Oncologica

Section

Articles